Recursion Pharmaceuticals (RXRX)
(Delayed Data from NSDQ)
$7.44 USD
+0.04 (0.54%)
Updated Jul 9, 2024 04:00 PM ET
After-Market: $7.44 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.38 | 7.89% |
Earnings Summary
For their last quarter, Recursion Pharmaceuticals (RXRX) reported earnings of -$0.39 per share, beating the Zacks Consensus Estimate of $-0.43 per share. This reflects a positive earnings surprise of 9.30%. Look out for RXRX's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.38 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for RXRX
Here is What to Know Beyond Why Recursion Pharmaceuticals, Inc. (RXRX) is a Trending Stock
RXRX: What are Zacks experts saying now?
Zacks Private Portfolio Services